Skip to main content

Table 1 IRU characteristics

From: Immune recovery uveitis in HIV patients with cytomegalovirus retinitis in the era of HAART therapy—a 5-year study from Singapore

Number of patients, n

30

Gender, n (%)

 Male

26 (86.7)

 Female

4 (13.3)

Race, n (%)

 Chinese

25 (83.3)

 Malay

3 (10.0)

 Indian

1 (3.3)

 Others

1 (3.3)

Age, years; mean (SD)

 At IRU diagnosis

47.9 (10.7)

CD4 count, cells/μL; median (IQR)

 At HAART commencement

20.0 (15.0–62.0)

 At IRU diagnosis

210.0 (139.8–289.5)

 At CMVR diagnosis

28.5 (10.5–61.8)

 Difference from HAART to IRU diagnosis

155.5 (66.0–228.0)

Duration, days; median (IQR)

 From HIV diagnosis to HAART commencement

100.5 (61.0–210.0)

 From HAART initiation to IRU diagnosis

214.0 (118.0–763.0)

 From CMVR diagnosis to IRU diagnosis

136.5 (26.0–618.5)